Nanobiotix Shares Drop 7.32% at Opening, Extending Its Decline
The biotechnology stock continues its retreat since Friday, losing over 7% at the start of the session.
Continued Downtrend from Friday
Nanobiotix fell 7.32% to €14.94 at the opening this Monday, continuing a decline that started last Friday, October 24. Over seven days, the cumulative losses amount to 33%, while trading volumes remain high with more than 1% of the capital in circulation, indicating active trading at current levels. However, the picture reverses over longer horizons: over three months, Nanobiotix had appreciated by 159.8%, and since the beginning of the year, the stock is still up 259.1%, significantly outperforming the CAC 40, which is up 9.62% over twelve months.
Technical Indicators Show Mixed Signals
The Relative Strength Index at 43 indicates a neutral technical situation, while a negative MACD histogram at -1.01 confirms persistent selling pressure. The stock remains above its 50-day moving average set at €13.23, a level that frames the short term without altering the current downward trend.
Comfortable Margin Above Technical Support
The price maintains a comfortable gap from the technical support at €7.95. The monthly volatility of 36.48% illustrates the exceptional range of fluctuations, well beyond those observed in the segment's values. Furthermore, Nanobiotix has a beta of 0.24, indicating almost complete isolation from general market movements; the CAC 40 was down just 0.08% at the opening, thus highlighting the unique dynamics of the biotechnological stock.
